HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vitro susceptibility and molecular characterization of Candida spp. from candidemic patients.

AbstractBACKGROUND:
Candida species are the main cause of hospital acquired fungal bloodstream infections. The main risk factors for candidemia include parenteral nutrition, long-term intensive care, neutropenia, diabetes, abdominal surgery and the use of central venous catheters. The antifungal drugs used to treat candidemia are mainly the echinocandins, however some isolates may be resistant to these drugs.
AIMS:
This work aims to evaluate the in vitro susceptibility patterns of various Candida species isolated from blood samples and provide their identification by molecular characterization.
METHODS:
Antifungal susceptibility testing was performed using the broth microdilution method. The sequencing of the ITS and D1/D2 regions of rDNA was used for molecular characterization.
RESULTS:
Seventy-four of the 80 isolates were susceptible to anidulafungin, 5 were intermediate, and 1 was resistant. For micafungin 67 were susceptible, 8 were intermediate and 5 were resistant. All isolates were susceptible to amphotericin B. Lastly, 65 isolates were susceptible to fluconazole, 8 were dose-dependent and 4 were resistant. The molecular identification corroborated the phenotypic data in 91.3% of the isolates.
CONCLUSIONS:
Antifungal susceptibility data has an important role in the treatment of candidemia episodes. It was also concluded that the molecular analysis of isolates provides an accurate identification and identifies genetic variability within Candida species isolated from patients with candidemia.
AuthorsPatricia Fernanda Herkert, Renata Rodrigues Gomes, Marisol Dominguez Muro, Rosangela Lameira Pinheiro, Gheniffer Fornari, Vânia Aparecida Vicente, Flávio Queiroz-Telles
JournalRevista iberoamericana de micologia (Rev Iberoam Micol) 2015 Oct-Dec Vol. 32 Issue 4 Pg. 221-8 ISSN: 2173-9188 [Electronic] Spain
PMID25681153 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Revista Iberoamericana de Micología. Published by Elsevier Espana. All rights reserved.
Chemical References
  • Antifungal Agents
  • DNA, Fungal
Topics
  • Antifungal Agents (pharmacology, therapeutic use)
  • Candida (classification, drug effects, genetics, isolation & purification)
  • Candidemia (drug therapy, epidemiology, microbiology)
  • DNA, Fungal (genetics, isolation & purification)
  • Drug Resistance, Fungal (genetics)
  • Genes, Fungal
  • Humans
  • Likelihood Functions
  • Microbial Sensitivity Tests
  • Phylogeny
  • Spain (epidemiology)
  • Species Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: